Justin Huynh None;
Ruben Gonzalez None;
Evan Walker None;
Benton Chuter None;
Alireza Kamalipour None;
Christopher Bowd None;
Akram Belghith None;
Michael Goldbaum None;
Massimo Fazio National Eye Institute, EyeSight Foundation of Alabama, Research to Prevent Blindness, Heidelberg Engineering, GmbH, Topcon and Wolfram Research, Code F (Financial Support);
Christopher Girkin National Eye Institute, Heidelberg Engineering and Topcon, EyeSight Foundation of Alabama, Research to Prevent Blindness, Heidelberg Engineering, GmbH, Code F (Financial Support);
Carlos Moraes Novartis, Galimedix, Belite, Reichert, Carl Zeiss, Perfuse Therapeutics, Code C (Consultant/Contractor), Ora Clinical, Code E (Employment), Heidelberg, Topcon, Code R (Recipient);
Jeffrey Liebmann Allergan, Genentech, Thea, Bausch & Lomb, Code C (Consultant/Contractor), Novartis, Research to Prevent Blindness, Code F (Financial Support);
Robert Weinreb Abbvie, Aerie Pharmaceuticals, Alcon, Allergan, Equinox, Iantrek, Implandata, Nicox, Santen, Topcon Medical, Code C (Consultant/Contractor), Topcon Medical, Heidelberg Engineering, Carl Zeiss Meditec, Optovue, Centervue, National Eye Institute, National Institute of Minority Health and Disparities, Research to Prevent Blindness , Code F (Financial Support), Toromedes, Carl Zeiss Meditec, Code P (Patent);
Sally Baxter voxelcloud.io, Code C (Consultant/Contractor), Optomed, Topcon, Code F (Financial Support), iVista Medical Education, Code R (Recipient);
Linda Zangwill Abbvie Inc., Topcon, Code C (Consultant/Contractor), National Eye Institute, Carl Zeiss Meditec Inc., Heidelberg Engineering GmbH, Optovue Inc., Topcon Medical Systems Inc., Code F (Financial Support), Carl Zeiss Meditec, AISight Health, Code P (Patent);
Mark Christopher AISight Health, Code P (Patent)